These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Engineered nanostructural materials for application in cancer biology and medicine. Mahmood M; Casciano D; Xu Y; Biris AS J Appl Toxicol; 2012 Jan; 32(1):10-9. PubMed ID: 21882206 [TBL] [Abstract][Full Text] [Related]
26. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment. Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679 [TBL] [Abstract][Full Text] [Related]
27. Layered double hydroxide nanoparticles in gene and drug delivery. Ladewig K; Xu ZP; Lu GQ Expert Opin Drug Deliv; 2009 Sep; 6(9):907-22. PubMed ID: 19686052 [TBL] [Abstract][Full Text] [Related]
29. What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature. Boczkowski J; Hoet P Nanotoxicology; 2010 Mar; 4(1):1-14. PubMed ID: 20795899 [TBL] [Abstract][Full Text] [Related]
30. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Gao J; Gu H; Xu B Acc Chem Res; 2009 Aug; 42(8):1097-107. PubMed ID: 19476332 [TBL] [Abstract][Full Text] [Related]
31. Drug-incorporating calcium carbonate nanoparticles for a new delivery system. Ueno Y; Futagawa H; Takagi Y; Ueno A; Mizushima Y J Control Release; 2005 Mar; 103(1):93-8. PubMed ID: 15710503 [TBL] [Abstract][Full Text] [Related]
32. Nanoparticles for direct nose-to-brain delivery of drugs. Mistry A; Stolnik S; Illum L Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750 [TBL] [Abstract][Full Text] [Related]
33. Safety assessment of nanomaterials: implications for nanomedicine. Nyström AM; Fadeel B J Control Release; 2012 Jul; 161(2):403-8. PubMed ID: 22306428 [TBL] [Abstract][Full Text] [Related]
34. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Kunzmann A; Andersson B; Thurnherr T; Krug H; Scheynius A; Fadeel B Biochim Biophys Acta; 2011 Mar; 1810(3):361-73. PubMed ID: 20435096 [TBL] [Abstract][Full Text] [Related]
36. New frontiers in nanotechnology for cancer treatment. Alexis F; Rhee JW; Richie JP; Radovic-Moreno AF; Langer R; Farokhzad OC Urol Oncol; 2008; 26(1):74-85. PubMed ID: 18190835 [TBL] [Abstract][Full Text] [Related]
37. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. Zolnik BS; Sadrieh N Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437 [TBL] [Abstract][Full Text] [Related]
38. The use of microorganisms for the formation of metal nanoparticles and their application. Mandal D; Bolander ME; Mukhopadhyay D; Sarkar G; Mukherjee P Appl Microbiol Biotechnol; 2006 Jan; 69(5):485-92. PubMed ID: 16317546 [TBL] [Abstract][Full Text] [Related]
39. Composite nanoparticles take aim at cancer. Gil PR; Parak WJ ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383 [TBL] [Abstract][Full Text] [Related]
40. Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. Nunes A; Al-Jamal KT; Kostarelos K J Control Release; 2012 Jul; 161(2):290-306. PubMed ID: 22512901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]